org placeholder image

Raf Lambrecht

Vice President, Head of Regulatory Affairs at Nurix Therapeutics

  • LinkedIn

Email Email: r****@fibrogen.com

phone noPhone Number: (***)-***-****

map
NURIX THERAPEUTICS

NURIX THERAPEUTICS

  • description Description
    Nurix Therapeutics discovers drugs that harness the body's natural process to control protein levels. Our drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown...

    Read More

  • Employees count Employees 201-500
  • Revenue Revenue 10 Million to 25 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Nurix Therapeutics Org Chart and Mapping

Employees

Zhifen Yang

Director, Cell Therapy

Paul Novick

Director, Machine Learning and Cheminformatics

Emel Ficici

Senior Scientist, Computational Chemistry

Monica Singh

Senior Manager, Safety Science

Thao Nguyen

Associate Director, Manufacturing Operations

Frequently Asked Questions Regarding Raf Lambrecht

Answer: Raf Lambrecht works for Nurix Therapeutics as Vice President, Head of Regulatory Affairs

Answer: Raf Lambrecht’s role in Nurix Therapeutics is Vice President, Head of Regulatory Affairs

Answer: Raf Lambrecht's email address is r***@gmail.com

Answer: Raf Lambrecht's business email address is r****@fibrogen.com

Answer: Raf Lambrecht’s direct phone number is (***)-***-****

Answer: Raf Lambrecht works in the industry of: Biotechnology

Answer: Raf Lambrecht works Nurix Therapeutics located at 1700 Owens St Ste 205, San Francisco, California, 94158, United States

Answer: Nurix Therapeutics's Vice President, Head of Regulatory Affairs is Raf Lambrecht

Answer: Raf Lambrecht contact details:

  • Phone number  :  (***)-***-****
  • Email  :  r****@fibrogen.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access